YEM Search

搜索结果

PEPD

靶点ID:TCMBANKGE011999

靶点别名:PROLIDASE

靶点描述:peptidase D

染色体:19

染色体位置:19q13.11

靶点类型:protein-coding

HERB_ID:-

HGNC_Link:8840

OMIM_Link:613230

Ensembl_Link:ENSG00000124299

靶点对应的植物

ID	拉丁名	药名	药用植物名	功能与主治	来源	药用部位	使用民族

靶点对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN029312	melanin	AKOS030232017; FT-0628190; 6,14-dimethyl-4,12-diazapentacyclo[8.6.1.1;{2,5}.0;{13,17}.0;{9,18}]octadeca-1(17),2,5,9(18),10,13-hexaene-7,8,15,16-tetrone; CHEBI:89634; D0WQ4G; API0003281; CTK8G0775; 8049-97-6; XUMBMVFBXHLACL-UHFFFAOYSA-N; Phaeomelanins; Melanin; 6,14-dimethyl-4,12-diazapentacyclo[8.6.1.1^{2,5}.0^{13,17}.0^{9,18}]octadeca-1(17),2,5,9(18),10,13-hexaene-7,8,15,16-tetrone; GTPL5415; Melanin from Sepia officinalis	C18H10N2O4	318.3 g/mol	CC1=C2C3=C(C4=CNC5=C(C(=O)C(=O)C(=C45)C3=CN2)C)C(=O)C1=O
TCMBANKIN033702	citric acid	InChI=1/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12; NCGC00090954-02; NCGC00090954-01; HSDB 911; CIT; Citric acid (8CI); BRN 0782061; NCIStruc2_000099; 27109_RIEDEL; AIDS-017733; 1,2,3-PROPANETRICARBOXYLIC ACID,2-HYDROXY (CITRIC ACID); citr; 27488_FLUKA; FEMA No. 2306; E 330; 27485_FLUKA; 27487_FLUKA; 77-92-9; C2404_SIGMA; 2-Hydroxytricarballylic acid; NCIOpen2_004502; F 0001 (polycarboxylic acid); EPA Pesticide Chemical Code 021801; AI3-06286; 245654-34-6; 1,2,3-Propanetricarboxylic acid, 2-hydroxy-; Citretten; Kyselina citronova; 2-hydroxypropane-1,2,3-tricarboxylic acid; Anhydrous citric acid; Citrate standard for IC; C83155_SIAL; LS-2418; WLN: QV1XQVQ1VQ; 1,2,3-Propanetricarboxylic acid, 2-hydroxy- (9CI); NSC30279; .beta.-Hydroxytricarballylic acid; NSC 626579; FLC; NCI60_022579; LS-3185; 2-hydroxy-1,2,3-propanetricarboxylic acid; Caswell No. 221C; EINECS 201-069-1; 43136-35-2; 251275_SIAL; 38730_FLUKA; C4540_SIGMA; FEMA Number 2306; 4-03-00-01272 (Beilstein Handbook Reference); 3-Carboxy-3-hydroxypentane-1,5-dioic acid; Citric acid anhydrous (JAN); C00158; 12262-73-6; 240621_ALDRICH; AIDS017733; MLS001066346; Kyselina 2-hydroxy-1,2,3-propantrikarbonova [Czech]; 2-Hydroxypropanetricarboxylic acid; CCRIS 3292; KBio3_002740; NSC626579; D00037; SBB008922; Kyselina citronova [Czech]; Aciletten; NSC 30279; Anhydrous citric acid (JP15); 46933_SUPELCO; NCIOpen2_004062; Citric acid solution; CHEBI:30769; Citro; BSPBio_003240; NCIStruc1_000057; Uro-trainer; Citric acid, anhydrous (USP); W230618_ALDRICH; Citric acid [USAN:JAN]; H3cit; Chemfill; Hydrocerol A; Suby G; Oprea1_502996; Citric acid, anhydrous; SMR000471840; Citric acid anhydrous; Spectrum3_001850	C6H8O7	192.12	C(C(=O)O)C(CC(=O)O)(C(=O)O)O
TCMBANKIN057905	ferrum	iron	Fe	55.84 g/mol	[Fe]
TCMBANKIN058277	2-hydroxybenzoic acid	O-hydroxybenzoic acid; 3- coffee acid; Thick-stemmed black base	C7H6O3 or HOC6H4COOH	138.12 g/mol	C1=CC=C(C(=C1)C(=O)O)O

靶点对应的疾病

疾病ID	疾病名	MeSH名	HPO名	UMLS名	疾病类型

TCMBANKDI000023	Skin and Connective Tissue Diseases; Immune System Diseases	Abnormality of the immune system	Disease or Syndrome	disease
TCMBANKDI000802	Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases	Abnormality of the integument	Finding	phenotype
TCMBANKDI001706	Musculoskeletal Diseases	Abnormality of limbs; Abnormality of the skeletal system	Disease or Syndrome	disease
TCMBANKDI002340	Respiratory Tract Diseases	Abnormality of the respiratory system	Disease or Syndrome	disease
TCMBANKDI003248	Nutritional and Metabolic Diseases; Endocrine System Diseases	Abnormality of metabolism/homeostasis; Abnormality of the endocrine system	Disease or Syndrome	disease
TCMBANKDI003561	Cardiovascular Diseases	Abnormality of the cardiovascular system	Disease or Syndrome	disease
TCMBANKDI005810	Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases	Abnormality of the genitourinary system; Abnormality of the immune system	Disease or Syndrome	disease
TCMBANKDI007618	Hemic and Lymphatic Diseases	Abnormality of blood and blood-forming tissues	Disease or Syndrome	phenotype
TCMBANKDI007832	Cardiovascular Diseases	-	Disease or Syndrome	phenotype
TCMBANKDI009571	Cardiovascular Diseases	Abnormality of the cardiovascular system	Disease or Syndrome	disease
TCMBANKDI011194	-	-	Finding	phenotype
TCMBANKDI011743	Neoplasms; Skin and Connective Tissue Diseases	Neoplasm; Abnormality of the breast	Neoplastic Process	group
TCMBANKDI011758	-	-	Laboratory Procedure	phenotype
TCMBANKDI013169	-	Abnormality of the skeletal system	Anatomical Abnormality	disease
TCMBANKDI015401	Infections; Nervous System Diseases	-	Disease or Syndrome	disease
TCMBANKDI015485	Mental Disorders	Abnormality of the nervous system	Mental or Behavioral Dysfunction	disease
TCMBANKDI017673	-	-	Clinical Attribute	phenotype
TCMBANKDI018929	Eye Diseases	Abnormality of the eye	Disease or Syndrome	disease
TCMBANKDI019682	-	Abnormality of head or neck; Abnormality of the skeletal system	Anatomical Abnormality	disease
TCMBANKDI020449	Skin and Connective Tissue Diseases	Abnormality of the integument	Pathologic Function	phenotype
TCMBANKDI021151	-	Abnormality of the skeletal system	Finding	phenotype
TCMBANKDI024559	-	Abnormality of head or neck	Finding	phenotype
TCMBANKDI025355	-	-	Laboratory Procedure	phenotype
TCMBANKDI025502	-	-	Laboratory Procedure	phenotype
TCMBANKDI028357	Pathological Conditions, Signs and Symptoms; Infections; Musculoskeletal Diseases	Abnormality of the immune system	Finding	phenotype
TCMBANKDI030137	Skin and Connective Tissue Diseases	Abnormality of the integument	Finding	phenotype
TCMBANKDI031417	Skin and Connective Tissue Diseases	Abnormality of the integument	Sign or Symptom	phenotype
TCMBANKDI031570	-	Abnormality of the nervous system	Mental or Behavioral Dysfunction	disease
TCMBANKDI032109	Pathological Conditions, Signs and Symptoms	-	Disease or Syndrome	disease